A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis

References

• Carvalho AV, Romiti R, Souza CD, et al. Psoriasis comorbidities: complications and benefits of immunobiological treatment. An Bras Dermatol. 2016;91(6):781–789.
   PubMed Web of Science ®Google Scholar
• Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029–1072.
   PubMed Web of Science ®Google Scholar
• Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851–864.
   PubMed Web of Science ®Google Scholar
• Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019;80(1):251–265.e19.
   PubMed Web of Science ®Google Scholar
• Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(21):2095–2096.
   PubMedGoogle Scholar
• Krueger JG, Brunner PM. Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities. Exp Dermatol. 2018;27(2):115–123.
   PubMed Web of Science ®Google Scholar
• Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther. 2016;3(1):91–102.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14–ii17.
   PubMed Web of Science ®Google Scholar
• Merola JF, Herrera V, Palmer JB. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA. Clin Rheumatol. 2018;37(10):2751–2761.
   PubMed Web of Science ®Google Scholar
• Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045–1050.
   PubMed Web of Science ®Google Scholar
• Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55–78.
   PubMedGoogle Scholar
• Eder L, Polachek A, Rosen CF, et al. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol. 2017;69(3):622–629.
   PubMed Web of Science ®Google Scholar
• Haberman R, Perez-Chada L, Chandran V, et al. A Delphi consensus study to standardize terminology for the pre-clinical phase of psoriatic arthritis. Presented at the American College of Rheumatology Convergence 2020. Poster #0305.
   Google Scholar
• Scher JU, Ogdie A, Merola JF, et al. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153–166.
   PubMed Web of Science ®Google Scholar
• Lebwohl MG, Kavanaugh A, Armstrong AW, et al. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Am J Clin Dermatol. 2016;17(1):87–97.
   PubMed Web of Science ®Google Scholar
• Kirkham B, de Vlam K, Li W, et al. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol. 2015;33(1):11–19.
   PubMed Web of Science ®Google Scholar
• Ogdie A, Nowell WB, Applegate E, et al. Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States. BMC Rheumatol. 2020;4:2.
   PubMedGoogle Scholar
• Menon B, Gullick NJ, Walter GJ, et al. Interleukin-17 + CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol. 2014;66(5):1272–1281.
   PubMed Web of Science ®Google Scholar
• Coates LC, Gossec L, Ramiro S, et al. New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. Rheumatology. 2017;56(8):1251–1253.
   PubMed Web of Science ®Google Scholar
• Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79(6):700–712.
   PubMed Web of Science ®Google Scholar
• Radtke MA, Reich K, Blome C, et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol. 2009;23(6):683–691.
   PubMed Web of Science ®Google Scholar
• Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–740.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–735.
   PubMed Web of Science ®Google Scholar
• Villani AP, Rouzaud M, Sevrain M, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242–248.
   PubMed Web of Science ®Google Scholar
• Reich K, Krüger K, Mössner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040–1047.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Palmer JB, Hur P, et al. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry. J Eur Acad Dermatol Venereol. 2019;33(5):886–892.
   PubMed Web of Science ®Google Scholar
• Elnady B, El Shaarawy NK, Dawoud NM, et al. Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years. Clin Rheumatol. 2019;38(6):1627–1635.
   PubMed Web of Science ®Google Scholar
• Acquitter M, Misery L, Saraux A, et al. Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis. Joint Bone Spine. 2017;84(6):703–707.
   PubMed Web of Science ®Google Scholar
• Naredo E, Möller I, de Miguel E, et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology. 2011;50(10):1838–1848.
   PubMed Web of Science ®Google Scholar
• Faustini F, Simon D, Oliveira I, et al. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. Ann Rheum Dis. 2016;75(12):2068–2074.
   PubMed Web of Science ®Google Scholar
• Acquacalda E, Albert C, Montaudie H, et al. Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: a prospective study. Joint Bone Spine. 2015;82(4):267–271.
   PubMed Web of Science ®Google Scholar
• Tinazzi I, McGonagle D, Biasi D, et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol. 2011;38(12):2691–2692.
   PubMed Web of Science ®Google Scholar
• Gutierrez M, Filippucci E, De Angelis R, et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40(5):407–412.
   PubMed Web of Science ®Google Scholar
• Perrotta FM, Astorri D, Zappia M, et al. An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment. Rheumatol Int. 2016;36(11):1579–1583.
   PubMed Web of Science ®Google Scholar
• El Miedany Y, El Gaafary M, Youssef S, et al. Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage. Clin Rheumatol. 2015;34(2):307–313.
   PubMed Web of Science ®Google Scholar
• Naredo E, Janta I, Baniandres-Rodriguez O, et al. To what extend is nail ultrasound discriminative between psoriasis, psoriatic arthritis and healthy subjects? Rheumatol Int. 2019;39(4):697–705.
   PubMed Web of Science ®Google Scholar
• Aluja Jaramillo F, Quiasúa Mejía DC, Martínez Ordúz HM, et al. Nail unit ultrasound: a complete guide of the nail diseases. J Ultrasound. 2017;20(3):181–192.
   PubMed Web of Science ®Google Scholar
• Ash ZR, Tinazzi I, Gallego CC, et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis. 2012;71(4):553–556.
   PubMed Web of Science ®Google Scholar
• Glinatsi D, Bird P, Gandjbakhch F, et al. Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial. J Rheumatol. 2015;42(12):2473–2479.
   PubMed Web of Science ®Google Scholar
• Ostergaard M, McQueen F, Wiell C, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands. J Rheumatol. 2009;36(8):1816–1824.
   PubMed Web of Science ®Google Scholar
• Mathew AJ, Bird P, Gupta A, et al. Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis. Clin Rheumatol. 2018;37(2):383–388.
   PubMed Web of Science ®Google Scholar
• Tinazzi I, Adami S, Zanolin EM, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology. 2012;51(11):2058–2063.
   PubMed Web of Science ®Google Scholar
• Mandl P, Navarro-Compan V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74(7):1327–1339.
   PubMed Web of Science ®Google Scholar
• Sudoł-Szopińska I, Matuszewska G, Kwiatkowska B, et al. Diagnostic imaging of psoriatic arthritis. Part I: etiopathogenesis, classifications and radiographic features. J Ultrason. 2016;16(64):65–77.
   PubMed Web of Science ®Google Scholar
• Raza N, Hameed A, Ali MK. Detection of subclinical joint involvement in psoriasis with bone scintigraphy and its response to oral methotrexate. Clin Exp Dermatol. 2008;33(1):70–73.
   PubMed Web of Science ®Google Scholar
• Catanoso M, Pipitone N, Salvarani C. Epidemiology of psoriatic arthritis. Reumatismo. 2012;64(2):66–70.
   PubMedGoogle Scholar
• Ogdie A, Gelfand JM. Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: a review of available evidence. Curr Rheumatol Rep. 2015;17(10):64.
   PubMed Web of Science ®Google Scholar
• Busse K, Liao W. Which psoriasis patients develop psoriatic arthritis? Psoriasis Forum. 2010;16(4):17–25.
   PubMedGoogle Scholar
• Wilson FC, Icen M, Crowson CS, et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233–239.
   PubMed Web of Science ®Google Scholar
• Soltani-Arabshahi R, Wong B, Feng BJ, et al. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721–726.
   PubMedGoogle Scholar
• Eder L, Haddad A, Rosen CF, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol. 2016;68(4):915–923.
   PubMed Web of Science ®Google Scholar
• Tey HL, Ee HL, Tan AS, et al. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010;37(5):426–430.
   PubMed Web of Science ®Google Scholar
• Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatolog Treat. 2020;31(7):662–679.
   PubMed Web of Science ®Google Scholar
• Patrizi A, Venturi M, Scorzoni R, et al. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? G Ital Dermatol Venereol. 2014;149(2):177–184.
   PubMed Web of Science ®Google Scholar
• Castellanos-Gonzalez M, Joven BE, Sanchez J, et al. Nail involvement can predict enthesopathy in patients with psoriasis. J Dtsch Dermatol Ges. 2016;14(11):1102–1107.
   Web of Science ®Google Scholar
• Langenbruch A, Radtke MA, Krensel M, et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol. 2014;171(5):1123–1128.
   PubMed Web of Science ®Google Scholar
• Sobolewski P, Walecka I, Dopytalska K. Nail involvement in psoriatic arthritis. Reumatologia. 2017;55(3):131–135.
   PubMedGoogle Scholar
• Raposo I, Torres T. Nail psoriasis as a predictor of the development of psoriatic arthritis. Actas Dermosifiliogr. 2015;106(6):452–457.
   PubMed Web of Science ®Google Scholar
• Rouzaud M, Sevrain M, Villani AP, et al. Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol. 2014;28(Suppl 5):17–26.
   PubMedGoogle Scholar
• Eder L, Chandran V, Gladman DD. What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Curr Opin Rheumatol. 2015;27(1):91–98.
   PubMed Web of Science ®Google Scholar
• Oliveira MF, Rocha BO, Duarte GV. Psoriasis: classical and emerging comorbidities. An Bras Dermatol. 2015;90(1):9–20.
   PubMed Web of Science ®Google Scholar
• Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res. 2011;63(12):1729–1735.
   PubMed Web of Science ®Google Scholar
• Chandran V, Schentag CT, Brockbank JE, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis. 2009;68(5):664–667.
   PubMed Web of Science ®Google Scholar
• Karason A, Love TJ, Gudbjornsson B. A strong heritability of psoriatic arthritis over four generations–the Reykjavik Psoriatic Arthritis Study. Rheumatology. 2009;48(11):1424–1428.
   PubMed Web of Science ®Google Scholar
• Belasco J, Wei N. Psoriatic arthritis: what is happening at the joint? Rheumatol Ther. 2019;6(3):305–315.
   PubMed Web of Science ®Google Scholar
• Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med. 2017;17(1):65–70.
   PubMed Web of Science ®Google Scholar
• Simon D, Tascilar K, Kleyer A, et al. Structural entheseal lesions in patients with psoriasis are associated with an increased risk of progression to psoriatic arthritis. Arthritis Rheumatol. 2020;2020:41239.
   Google Scholar
• McGonagle DG, Helliwell P, Veale D. Enthesitis in psoriatic disease. Dermatology. 2012;225(2):100–109.
   PubMed Web of Science ®Google Scholar
• Poggenborg RP, Eshed I, Ostergaard M, et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by ‘head-to-toe’ whole-body MRI and clinical examination. Ann Rheum Dis. 2015;74(5):823–829.
   PubMed Web of Science ®Google Scholar
• Feld J, Chandran V, Haroon N, et al. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363–371.
   PubMed Web of Science ®Google Scholar
• Generali E, Scirè CA, Favalli EG, et al. Biomarkers in psoriatic arthritis: a systematic literature review. Expert Rev Clin Immunol. 2016;12(6):651–660.
   PubMed Web of Science ®Google Scholar
• Punzi L, Poswiadek M, Oliviero F, et al. Laboratory findings in psoriatic arthritis. Reumatismo. 2011;59(1s):52–55.
   Google Scholar
• van der Heijde D, Gladman DD, FitzGerald O, et al. Radiographic progression according to baseline C-reactive protein levels and other risk factors in psoriatic arthritis treated with tofacitinib or adalimumab. J Rheumatol. 2019;46(9):1089–1096.
   PubMed Web of Science ®Google Scholar
• Bagel J, Schwartzman S. Enthesitis and dactylitis in psoriatic disease: a guide for dermatologists. Am J Clin Dermatol. 2018;19(6):839–852.
   PubMed Web of Science ®Google Scholar
• Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol. 2009;27(3):469–474.
   PubMed Web of Science ®Google Scholar
• Husni ME, Meyer KH, Cohen DS, et al. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol. 2007;57(4):581–587.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2009;68(4):497–501.
   PubMed Web of Science ®Google Scholar
• Tom BD, Chandran V, Farewell VT, et al. Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2). J Rheumatol. 2015;42(5):841–846.
   PubMed Web of Science ®Google Scholar
• Coates LC, Savage L, Waxman R, et al. Comparison of screening questionnaires to identify psoriatic arthritis in a primary-care population: a cross-sectional study. Br J Dermatol. 2016;175(3):542–548.
   PubMed Web of Science ®Google Scholar
• Dominguez PL, Husni ME, Holt EW, et al. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res. 2009;301(8):573–579.
   PubMed Web of Science ®Google Scholar
• Coates LC, Aslam T, Al Balushi F, et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol. 2013;168(4):802–807.
   PubMed Web of Science ®Google Scholar
• Helliwell PS. Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting. J Rheumatol. 2011;38(3):551–552.
   PubMedGoogle Scholar
• Cohen JM, Husni ME, Qureshi AA, et al. Psoriatic arthritis: it’s as easy as “PSA”. J Am Acad Dermatol. 2015;72(5):905–906.
   PubMed Web of Science ®Google Scholar
• Gossec L, de Wit M, Kiltz U, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73(6):1012–1019.
   PubMed Web of Science ®Google Scholar
• Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am. 2009;35(4):773–778.
   PubMed Web of Science ®Google Scholar
• Iragorri N, Hazlewood G, Manns B, et al. Psoriatic arthritis screening: a systematic review and meta-analysis. Rheumatology. 2019;58(4):692–707.
   PubMed Web of Science ®Google Scholar
• Perez-Chada LM, Kohn A, Gottlieb AB, et al. Report of the Skin Research Working Groups from the GRAPPA 2020 Annual Meeting. J Rheumatol. 2021;2020:201668.
   Google Scholar
• Coates LC, Kavanaugh A, Mease PJ, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68(5):1060–1071.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, Deodhar A, Fitzgerald O, et al. 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. RMD Open. 2018;4(1):e000582.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, Mease PJ, Landewé RBM, et al. Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5. Rheumatology. 2020;59(6):1325–1334.
   PubMed Web of Science ®Google Scholar
• Chandran V, van der Heijde D, Fleischmann RM, et al. Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1). Rheumatology. 2020;59(10):2774–2784.
   PubMed Web of Science ®Google Scholar
• Kampylafka E, D Oliveira I, Linz C, et al. OP0305 Disease interception in psoriasis patients with subclinical joint inflammation by interleukin 17 inhibition with secukinumab – data from a prospective open label study. Ann Rheum Dis. 2018;77:199.
   Web of Science ®Google Scholar
• Solmaz D, Ehlebracht A, Karsh J, et al. Evidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence. Clin Exp Rheumatol. 2020;38(2):257–261.
   PubMed Web of Science ®Google Scholar
• Kampylafka E, Simon D, d’Oliveira I, et al. Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study. Arthritis Res Ther. 2019;21(1):178.
   PubMedGoogle Scholar
• Savage L, Goodfield M, Horton L, et al. Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study. Arthritis Rheumatol. 2019;71(4):626–631.
   PubMed Web of Science ®Google Scholar
• Lininger N, Siegel S, Kiwalkar S, et al. FRI0555 Do TNF inhibitors decrease risk of incident psoriatic arthritis in psoriasis patients compared to those treated with methotrexate alone? Ann Rheum Dis. 2020;79(Suppl 1):879–880.
   Google Scholar